产品
编 号：F401311
分子式：C9H14ClNO2
分子量：203.67
分子式：C9H14ClNO2
分子量：203.67
产品类型
规格
价格
是否有货
10mM*1mL in DMSO
询价
询价
1g
200
In-stock
5g
400
In-stock
结构图
CAS No: 5985-28-4
产品详情
生物活性：
Synephrine (Oxedrine) hydrochloride, an alkaloid, is an α-adrenergic and β-adrenergic agonist derived from the Citrus aurantium. Synephrine hydrochloride is a sympathomimetic compound and can be used for weight loss.
体内研究：
Synephrine (1 mg/kg; oral gavage; for 8 days; PVL and BDL rats) significantly ameliorates the hyperdynamic state in both PVL and BDL rats. The portal venous pressure in PVL and BDL rats, portal tributary blood flow and cardiac index are significantly reduced, while mean arterial pressure and systemic as well as portal territory vascular resistance are enhanced by treatment of Synephrine.Animal Model:Portal vein ligation (PVL) or bile duct ligation (BDL) rats
Dosage:1 mg/kg per 12 hours
Administration:Oral gavage; for 8 days
Result:The portal venous pressure in PVL and BDL rats, portal tributary blood flow and cardiac index were significantly reduced, while mean arterial pressure and systemic as well as portal territory vascular resistance were enhanced.
Synephrine (Oxedrine) hydrochloride, an alkaloid, is an α-adrenergic and β-adrenergic agonist derived from the Citrus aurantium. Synephrine hydrochloride is a sympathomimetic compound and can be used for weight loss.
体内研究：
Synephrine (1 mg/kg; oral gavage; for 8 days; PVL and BDL rats) significantly ameliorates the hyperdynamic state in both PVL and BDL rats. The portal venous pressure in PVL and BDL rats, portal tributary blood flow and cardiac index are significantly reduced, while mean arterial pressure and systemic as well as portal territory vascular resistance are enhanced by treatment of Synephrine.Animal Model:Portal vein ligation (PVL) or bile duct ligation (BDL) rats
Dosage:1 mg/kg per 12 hours
Administration:Oral gavage; for 8 days
Result:The portal venous pressure in PVL and BDL rats, portal tributary blood flow and cardiac index were significantly reduced, while mean arterial pressure and systemic as well as portal territory vascular resistance were enhanced.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备